events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Search
Login
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
events
News and Community
Content by Category
Artificial Intelligence in Health Tech
Medical Cloud Computing
Patient Engagement
EHR/EMR
Telehealth
Our Network
IT Tech News
CXO Insiders
Rev Tech News
Fin Tech News
HR Tech News
Client Papers
Soc News
Martech-News
Login
News and Community
Aptar Pharma
,
Drug Delivery
,
Elastomer Components
,
Healthcare Technology
,
Injectable Therapies
,
Pharmaceutical Packaging
,
Premia Precision
October 6, 2026
Aptar Pharma Introduces Premia™ Precision, Setting a New Quality Standard for Demanding Injectable Therapies
Aerosol Performance
,
Aptar Pharma
,
Biologic Medicines
,
Biologics Delivery
,
Drug Delivery
,
Dry Powder Formulations
,
Dry Powder Inhaler
,
Healthcare Technology
,
Inhalation Technology
,
Macquarie University
,
Pulmonary Drug Delivery
September 28, 2026
Aptar Pharma and Macquarie University Advance Inhaled Biologics Through ARC-Supported Program
Aptar Pharma
,
Biologics Development
,
Container Closure Integrity Testing
,
Drug Delivery Systems
,
Drug Development
,
Healthcare Technology
,
Injectable Therapies
,
Pharmaceutical Testing
,
System-level Framework
July 20, 2026
Aptar Pharma Introduces Integrated System-Level Framework for Injectable Drug Development
Aptar Pharma
,
Covirix Medical
,
Dry Powder Inhalation
,
Inhalable Antiviral Treatments
,
Nanopharm
,
Respiratory Medicine
March 13, 2026
Aptar Pharma and COVIRIX Medical Collaborate to Develop Inhalable Antiviral Treatments
Load More